|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-8-16
|
|
pubmed:abstractText |
There is great interest in the recently developed immunosuppressant NK026680, which is a derivative of triazolopyrimidine. Its unique chemical structure and action mechanism are completely different from those of conventional immunosuppressants.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/(S)-1-(5-hydroxy-1,5-dimethylhexyl)-...,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD86,
http://linkedlifedata.com/resource/pubmed/chemical/Concanavalin A,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Isoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogens,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
pubmed-author:AbeFuminoriF,
pubmed-author:EzakiTaichiT,
pubmed-author:FujinoMasayukiM,
pubmed-author:Funeshima-FujiNaokoN,
pubmed-author:HaraYoshiakiY,
pubmed-author:HatakeyamaKatsuyoshiK,
pubmed-author:KimuraHiromitsuH,
pubmed-author:LiXiao-KangXK,
pubmed-author:SatoYoshinobuY,
pubmed-author:TakaharaShiroS,
pubmed-author:TokunakaKazuhiroK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
407-14
|
|
pubmed:meshHeading |
pubmed-meshheading:17700168-Animals,
pubmed-meshheading:17700168-Antigens, CD86,
pubmed-meshheading:17700168-Cell Differentiation,
pubmed-meshheading:17700168-Cell Proliferation,
pubmed-meshheading:17700168-Cells, Cultured,
pubmed-meshheading:17700168-Concanavalin A,
pubmed-meshheading:17700168-Dendritic Cells,
pubmed-meshheading:17700168-Dose-Response Relationship, Drug,
pubmed-meshheading:17700168-Graft Survival,
pubmed-meshheading:17700168-Histocompatibility Antigens Class II,
pubmed-meshheading:17700168-Immunosuppressive Agents,
pubmed-meshheading:17700168-Isoantigens,
pubmed-meshheading:17700168-Liver Transplantation,
pubmed-meshheading:17700168-Male,
pubmed-meshheading:17700168-Mitogens,
pubmed-meshheading:17700168-Pyrimidines,
pubmed-meshheading:17700168-Rats,
pubmed-meshheading:17700168-Rats, Inbred Lew,
pubmed-meshheading:17700168-T-Lymphocytes,
pubmed-meshheading:17700168-Triazoles
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A novel chemical compound, NK026680, targets dendritic cells to prolong recipient survival after rat liver grafting.
|
|
pubmed:affiliation |
Laboratory of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
